CHRISTINE FORSZPANIAK, M.D.
Infectious Disease Physician in NAPLES, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
CHRISTINE FORSZPANIAK, M.D. reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 707 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 707
- Part D claims, 2023
- 95%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
CHRISTINE FORSZPANIAK, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
CHRISTINE FORSZPANIAK, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about CHRISTINE FORSZPANIAK, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Florida
How Infectious Disease Physician compares to other specialties among Florida providers
Infectious Disease Physician share within Florida
Infectious Disease Physician is one of the more visible NUCC categories in Florida
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
CHRISTINE FORSZPANIAK, M.D.'s 2023 MIPS final score plotted against the Infectious Disease Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Infectious Disease Physician) — 75/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Specialty volume Infectious Disease Physician US NPIs
75/100 MIPS final score — 8.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Infectious Disease Physician.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
CHRISTINE FORSZPANIAK, M.D. appears in the CMS NPPES registry as a Infectious Disease Physician provider holding M.D. credentials at 848 1ST AVE N, NAPLES, FL, 34102, with a listed phone of (239) 434-7779. NPI 1841488111 was issued on 10/11/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FORSZPANIAK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 707 prescription claims written by this provider, covering 214 Medicare beneficiaries and totaling roughly $72K in drug spend, split 5% brand-name and 95% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Infectious Disease Physician is a mid-sized specialty nationwide, with 8,292 enrolled providers across 54 states and an average of 816 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1841488111 |
|---|---|
| Specialty | Infectious Disease Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 10/11/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm CHRISTINE FORSZPANIAK, M.D.'s current license status, disciplinary history, and board certifications with the Florida Board of Medicine in Florida before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
License & disciplinary context — Florida FLDOH 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to CHRISTINE FORSZPANIAK, M.D.. To verify CHRISTINE FORSZPANIAK, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
5% brand-name claims vs 95% generic, on 707 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 953
- Total Day Supply
- 20,436
- Brand vs Generic
- 5% brand / 95% generic
- Brand Drug Cost
- $24K
- Generic Drug Cost
- $48K
- Antibiotic Claims
- 442
Patient Demographics
- Average Patient Age
- 78.4 years
- Avg HCC Risk Score
- 2.70
- Gender Split
- 61% female / 39% male
- Age Distribution
- <65: 12, 65-74: 52, 75-84: 95, 85+: 55
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What CHRISTINE FORSZPANIAK, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Doxycycline Hyclate
Doxycycline Hyclate
91 claims
- Azithromycin
Azithromycin
74 claims
- Ethambutol Hcl
Ethambutol Hcl
62 claims
- Rifampin
Rifampin
59 claims
- Clotrimazole-Betam…
Clotrimazole-Betamethasone
41 claims
- Levofloxacin
Levofloxacin
37 claims
- Amoxicillin-Clavul… 33
Amoxicillin-Clavulanate Potass
33 claims
- Cephalexin 27
Cephalexin
27 claims
| Drug | Claims |
|---|---|
| Doxycycline Hyclate | 91 |
| Azithromycin | 74 |
| Ethambutol Hcl | 62 |
| Rifampin | 59 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 41 |
| Levofloxacin | 37 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 33 |
| Cephalexin | 27 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 25 |
| Clarithromycin | 21 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Infectious Disease Physician Overview
How CHRISTINE FORSZPANIAK, M.D. fits within the Infectious Disease Physician landscape nationally.
CHRISTINE FORSZPANIAK, M.D.'s 707 claims are below the specialty average of 816.
Nearby Infectious Disease Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as FORSZPANIAK.
Compare Infectious Disease Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Florida
Frequently Asked Questions
What is CHRISTINE FORSZPANIAK, M.D.'s specialty? ▼
How much does CHRISTINE FORSZPANIAK, M.D. prescribe under Medicare Part D? ▼
What is CHRISTINE FORSZPANIAK, M.D.'s Medicare quality score? ▼
Where is CHRISTINE FORSZPANIAK, M.D. located? ▼
What is CHRISTINE FORSZPANIAK, M.D.'s NPI number? ▼
Does CHRISTINE FORSZPANIAK, M.D. prescribe more brand-name or generic drugs? ▼
How many Infectious Disease Physician providers are there in the US? ▼
What drugs does CHRISTINE FORSZPANIAK, M.D. prescribe most often? ▼
Does CHRISTINE FORSZPANIAK, M.D. accept Medicare? ▼
How can I verify CHRISTINE FORSZPANIAK, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology